Placebo_ on EU
![]() | VIII | 1,086 | 64.09% | 2,687 | 1,750 | 157 | 1.23 | 42.36% | — | +50% | ||||
![]() | X | 1,074 | 55.68% | 3,301 | 3,144 | 586 | 1.78 | 38.27% | — | +50% | ||||
![]() | IX | 962 | 57.59% | 2,453 | 1,208 | 1,023 | 1.15 | 29.11% | — | +48% | ||||
![]() | X | 869 | 56.73% | 3,312 | 3,080 | 971 | 1.56 | 39.01% | — | +57% | ||||
![]() | X | 865 | 58.61% | 2,649 | 2,728 | 427 | 1.42 | 42.54% | — | +52% | ||||
![]() | X | 808 | 58.04% | 3,488 | 2,911 | 1,094 | 1.78 | 38.61% | — | +56% | ||||
![]() | VIII | 774 | 61.89% | 4,079 | 2,294 | 799 | 1.90 | 41.34% | — | +63% | ||||
![]() | X | 757 | 55.09% | 2,212 | 1,948 | 180 | 1.04 | 47.16% | — | +35% | ||||
![]() | VIII | 687 | 58.95% | 3,597 | 2,364 | 317 | 1.67 | 40.17% | — | +75% | ||||
![]() | VI | 659 | 64.04% | 3,133 | 1,042 | 251 | 1.60 | 32.47% | — | +83% | ||||
![]() | X | 648 | 59.26% | 3,167 | 3,075 | 339 | 1.64 | 40.59% | — | +64% | ||||
![]() | VII | 639 | 59.94% | 2,407 | 1,461 | 76 | 1.29 | 51.80% | — | +60% | ||||
![]() | X | 609 | 61.74% | 2,633 | 2,590 | 449 | 1.37 | 46.96% | — | +35% | ||||
![]() | VIII | 584 | 60.27% | 2,840 | 1,609 | 702 | 1.21 | 33.05% | — | +51% | ||||
![]() | X | 573 | 57.24% | 3,249 | 2,967 | 1,041 | 1.47 | 35.78% | — | +52% | ||||
![]() | X | 569 | 59.58% | 3,359 | 2,877 | 852 | 1.67 | 41.83% | — | +71% | ||||
![]() | VIII | 562 | 60.85% | 4,479 | 2,717 | 856 | 1.90 | 39.15% | — | +82% | ||||
![]() | VIII | 539 | 59.55% | 2,732 | 1,818 | 346 | 1.17 | 40.45% | — | +63% | ||||
![]() | VI | 523 | 59.08% | 3,105 | 1,306 | 217 | 1.70 | 41.87% | — | +83% | ||||
![]() | VIII | 522 | 58.62% | 3,316 | 1,199 | 784 | 1.41 | 28.16% | — | +91% | ||||
![]() | VIII | 516 | 63.37% | 2,987 | 1,905 | 168 | 1.44 | 46.51% | — | +82% | ||||
![]() | VIII | 499 | 63.13% | 3,139 | 1,968 | 190 | 1.69 | 44.09% | — | +63% | ||||
![]() | IX | 447 | 60.63% | 3,133 | 1,471 | 1,221 | 1.19 | 25.95% | — | +63% | ||||
![]() | IX | 441 | 61.68% | 3,060 | 2,231 | 690 | 1.59 | 36.73% | — | +81% | ||||
![]() | X | 440 | 61.36% | 3,756 | 3,195 | 762 | 1.86 | 39.32% | — | +68% |